Latest News

Raed Al Dieri: Taking pathology from bit part to key player on the European oncology scene

With precision medicine, pathology has moved out of the labs and into the heart of clinical decision making. But the discipline still struggles to make its voice heard at the level of professional oncology societies [more]
Could covid-19 boost interest in drug repurposing in oncology?

During the covid-19 pandemic, a number of approved therapies have been assessed as potential treatments against the virus and its effects. It’s known as drug repurposing and has a long history in oncology research, with [more]
Will artificial intelligence revolutionise cancer therapeutics and care?

AI has started to impact oncology, with tools for quicker and more-accurate diagnostics, but its role in better interpreting genomic data is still to be realised. Rachel Brazil pinpoints the latest avenues where AI is [more]
Prognostic biomarkers: could they help doctors, patients and families to better navigate the end of life?

“We had to explain that the reason she had broken her hip was because she was getting weaker and essentially dying… At that stage knowing whether Mum had days or months left would have been [more]
Rare cancer care: Are European Reference Networks delivering on the promise?

With a bigger role for European Reference Networks foreseen for Europe’s post-pandemic future, we ask: are they fulfilling their mandate to improve the quality of diagnostics and care for patients with rare cancers? What value [more]